Phase II study of irinotecan in combination with bevacizumab in recurrent ovarian cancer
| Autor: | Musa, Fernanda, Pothuri, Bhavana, Blank, Stephanie V., Ling, Huichung T., Speyer, James L., Curtin, John, Boyd, Leslie, Li, Xiaochun, Goldberg, Judith D., Muggia, Franco, Tiersten, Amy |
|---|---|
| Zdroj: | In Gynecologic Oncology February 2017 144(2):279-284 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect